CClaimWatch
Defense counsel in 8 cases

Kevin M. McDonough

LATHAM & WATKINS LLP

Address of record
1271 Avenue of the Americas, New York, NY 10022, 212-906-1200
Email
kevin.mcdonough@lw.com
Phone
(212) 906-1200
Fax
Fax 212-751-4864

Contact details as filed with the court in the cases below.

8
Cases tracked
2 active · 6 settled
—
Plaintiff-side recovery
Disclosed settlement funds
$387.2M
Defense-side exposure
Resolved in settlements
5
Cases with values
of 8 tracked

Case history

Publicly tracked matters where this attorney is listed as counsel.

Defense counselActive litigation — no settlement yet

RealPage Antitrust Class Action

A proposed class action has been filed against RealPage, Inc., with the nature of suit listed as Anti-Trust. The caption and docket text do not provide specific factual allegations. The case appears to involve antitrust claims brought on behalf of a putative class.

Filed
April 23, 2025
Represents
AVALONBAY COMMUNITIES, INC.
Defense counselActive litigation — no settlement yet

American Wagering Data Breach Class Action

A proposed class action against American Wagering, Inc. and affiliated Caesars Entertainment entities, apparently concerning a data breach. The case has been stayed pending resolution of a consolidated data breach class action against Caesars Entertainment in Nevada. The docket does not provide further details on the alleged breach or harm.

Filed
December 4, 2024
Represents
AMERICAN WAGERING, INC., WILLIAM HILL NEVADA I, WILLIAM HILL NEVADA II, BRANDYWINE BOOKMAKING, LLC, WH NV III, LLC, CAESARS ENTERTAINMENT, INC., WILLIAM HILL NEW JERSEY, INC.
Defense counselSettled — claims closed

Hayward Holdings, Inc. Securities Litigation

Defendants Hayward Holdings, Inc., its CEO, and CFO allegedly made materially false and misleading statements and omissions regarding inventory, growth, and demand trends for Hayward's pool products during the class period. The allegations claim that the stock traded at artificially inflated prices as a result, and shareholders suffered damages when the truth was revealed and the stock price declined.

Settlement fund
$19.9M
Claim deadline
June 19, 2026
Represents
HAYWARD HOLDINGS, INC., KEVIN HOLLERAN, EIFION JONES
Defense counselSettled — claims closed

Hayward Holdings, Inc. Securities Litigation Settlement

Hayward Holdings, Inc. and its CEO and CFO allegedly made materially false and misleading statements and omissions regarding inventory, growth, and demand trends for Hayward's pool products during October 27, 2021 through July 28, 2022. As a result, Hayward's stock traded at artificially inflated prices, and shareholders suffered damages when the stock price declined after the alleged truth was revealed. Defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Settlement fund
$19.9M
Claim deadline
June 19, 2026
Represents
HAYWARD HOLDINGS, INC., KEVIN HOLLERAN, EIFION JONES
Defense counselSettled — claims closed

Virgin Galactic Holdings Securities Settlement

Plaintiffs claim that defendants violated federal securities laws in connection with publicly traded shares of Virgin Galactic Holdings, Inc. and Social Capital Hedosophia Holdings Corp. Defendants deny all wrongdoing and deny that they violated any laws or that any member of the settlement class suffered damages.

Settlement fund
$8.5M
Claim deadline
August 13, 2026
Represents
Virgin Galactic Holdings, Inc., Michael A. Colglazier, George Whitesides, Richard Branson, Chamath Palihapitiya
Defense counselSettled — claims closed

GPB Securities Settlement

This is a securities class action settlement against five audit and consulting firms (CohnReznick LLP, Crowe LLP, Margolin, Winer & Evens LLP, RSM US LLP, and WithumSmith+Brown, PC). The defendants have agreed to settle the lawsuit with final court approval granted on November 24, 2025.

Claim deadline
November 14, 2025
Represents
Crowe, LLP
Defense counselSettled — claims closed

Celgene Corporation Securities Litigation Settlement

Celgene Corporation and certain of its officers violated federal securities laws by making false and misleading statements regarding pharmaceutical drugs and drug candidates, including GED-0301, Otezla, and Ozanimod during the class period. The defendants' misconduct allegedly damaged investors who purchased Celgene common stock.

Settlement fund
$239M
Claim deadline
April 13, 2026
Represents
CELGENE CORPORATION, TERRIE CURRAN, PHILIPPE MARTIN
Defense counselSettled — claims closed

Novo Nordisk Securities Litigation Settlement

Novo Nordisk and three individual executives allegedly violated federal securities laws by making false and misleading statements about the company's business and financial results. The defendants deny all allegations and maintain they have valid defenses. The settlement was approved for $100 million in July 2022.

Settlement fund
$100M
Claim deadline
Represents
PricewaterhouseCoopers LLP

“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.